Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of Nottingham
- The University of Manchester
- Imperial College London
- University of Birmingham
- University of Cambridge;
- University of Cambridge
- University of Birmingham;
- Swansea University
- UNIVERSITY OF VIENNA
- University of Sheffield
- Cranfield University
- Newcastle University
- Queen's University Belfast
- The Open University
- University of East Anglia
- University of Warwick
- ;
- AALTO UNIVERSITY
- Abertay University
- Brunel University
- Brunel University London
- Edge Hill University
- Imperial College London;
- Oxford Brookes University
- The University of Manchester;
- UCL
- University College London
- University of Exeter
- University of Exeter;
- University of Leeds
- University of Oxford
- University of Strathclyde
- University of Strathclyde (UOS)
- University of Strathclyde;
- University of Sussex
- University of Westminster;
- 26 more »
- « less
-
Field
-
to commence on 1st October 2026 are now open at the School of Physical Sciences. The projects available are listed here: https://www.open.ac.uk/science/physical-science/phd-students/current-phd-studentships
-
), aptamers, and DNAzymes.[3] Notable recently also is the use of oligonucleotide sequences (mRNA) in the development of a vaccine for SARS CoV 2. Currently, twenty-two oligonucleotide therapeutics have been
-
EPSRC Centre for Doctoral Training (CDT) PhD in Digital Metal with Rolls-Royce (Enhanced Stipend) Development of Advanced Barrier Coatings for extreme environments Background Applicants are invited
-
to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with flexible working options, work-life balance initiatives and support for physical and mental health. You
-
University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with flexible working
-
the global development of targeted therapies. By filling this gap, the project aims to identify and validate promising novel chemical scaffolds to support the creation of potent, specific modulators
-
manufacturing process from early development stages. This PhD project aims to develop computational tools that incorporate late-stage development into early-stage process and reaction optimisation. The project
-
Factor (PEDF) is required for the development and maintenance of the mammalian retina, but regulation of its abundance and activity remain poorly understood. This PhD project will address a critical gap in
-
neuroprotective effects. Camptothecin – A clinically relevant anticancer agent targeting Topoisomerase I. In collaboration with Prozomix Ltd. (an industrial leader in enzyme development), this project will
-
an attractive annual tax-free stipend; Join a multidisciplinary cohort to benefit from peer-to-peer learning and transferable skills development. For full information about the programme, the research projects